JAK2 (V617F) mutation in healthy individuals

被引:28
|
作者
Passamonti, Francesco [1 ]
Rumi, Elisa
Pietra, Daniela
Lazzarino, Mario
Cazzola, Mario
机构
[1] Fdn IRCCS, Dept Haematol, Policlin San Matteo, Pavia, Italy
[2] Univ Pavia, Sch Med, I-27100 Pavia, Italy
关键词
polycythaemia vera; essential thrombocythaemia; myelofibrosis; JAK2; V617F; chronic myeloproliferative disorders;
D O I
10.1111/j.1365-2141.2006.06483.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:678 / 679
页数:3
相关论文
共 50 条
  • [21] JAK2 (V617F) Mutation and Cerebral Venous Thrombosis
    Martinelli, Ida
    Passamonti, Serena Maria
    Biguzzi, Eugenia
    Franchi, Franca
    Gianniello, Francesca
    Bucciarelli, Paolo
    Pietra, Daniela
    Mannucci, Pier Mannuccio
    Cazzola, Mario
    BLOOD, 2011, 118 (21) : 1433 - 1433
  • [22] The prevalence of JAK2 V617F mutation in myelodysplastic syndrome
    Antolic, M. Radic
    Zadro, R.
    Roncevic, P.
    Kinda, S. Basic
    Labar, B.
    BLOOD REVIEWS, 2007, 21 : S126 - S126
  • [23] Absence of JAK2 V617F mutation in gastric cancers
    Lee, JW
    Soung, YH
    Kim, SY
    Nam, SW
    Park, WS
    Lee, JY
    Yoo, NJ
    Lee, SH
    ACTA ONCOLOGICA, 2006, 45 (02) : 222 - 223
  • [24] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
    Hamidah, N.
    Farisah, N.
    Jalil, N.
    Fei-Liang, W.
    AWahid, F.
    Othman, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
  • [25] JAK2 V617F MUTATION SCANNING IN PATIENTS WITH ADRENAL INCIDENTALOMA
    Ekinci, F.
    Soyaltin, U. E.
    Kutbay, Y. B.
    Yasar, H. Y.
    Yildirim, T. Demirci
    Akar, H.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (02) : 150 - 153
  • [26] JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemia
    Johan, MF
    Goodeve, AC
    Bowen, DT
    Frew, ME
    Reilly, JT
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (06) : 968 - 968
  • [27] THE JAK2 V617F MUTATION IN RETINAL VEIN OR ARTERY OCCLUSION
    Langabeer, Stephen E.
    EXCLI JOURNAL, 2019, 18 : 127 - 128
  • [28] JAK2 V617F mutation positives in the general population.
    Bojesen, S. E.
    Nielsen, C.
    Birgens, H.
    Nordestgaard, B. G.
    Kjaer, L.
    Hasselbalch, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Prognostic relevance of JAK2 V617F mutation in primary myelofibrosis
    Barosi, G.
    Bergamaschi, G.
    Marchetti, M.
    Massa, M.
    Rosti, V.
    Bonetti, E.
    Vannucchi, A. M.
    Guglielmelli, P.
    Antonioli, E.
    Campanelli, R.
    Villani, L.
    Viarengo, G. L.
    Barbui, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 241 - 241
  • [30] Absence of JAK2 V617F mutation in thalassemia intermedia patients
    Taher, Ali
    Shammaa, Dina
    Bazarbachi, Ali
    Itani, Doha
    Zaatari, Ghazi
    Greige, Layal
    Otrock, Zaher K.
    Mahfouz, Rami A. R.
    MOLECULAR BIOLOGY REPORTS, 2009, 36 (06) : 1555 - 1557